Clinical trial
Microcirculatory Guided Goal Directed Fluid Therapy in Septic Shock; a Feasibility Study
NCT03898674 is registered in ClinicalTrials.gov with King's College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microcirculatory Guided Goal Directed Fluid Therapy in Septic Shock; a Feasibility Study
- Lead sponsor
- King's College London
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 5, 2019
- Completion date
- October 1, 2020
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock